Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sivaramakrishna P. Rachakonda"'
Autor:
Hao Dai, Sivaramakrishna P. Rachakonda, Olaf Penack, Igor W. Blau, Olga Blau, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, Rajiv Kumar, Thomas Luft
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-12 (2021)
Abstract Chronic graft-versus-host disease (cGVHD) is a major cause of mortality and morbidity after allogeneic stem cell transplantation (alloSCT). The individual risk of severe cGVHD remains difficult to predict and may involve CXCR3 ligands. This
Externí odkaz:
https://doaj.org/article/971e0d0bb95d481495b6e90192e86eeb
Autor:
Aleksandar Radujkovic, Hao Dai, Lambros Kordelas, Dietrich Beelen, Sivaramakrishna P. Rachakonda, Carsten Müller-Tidow, Rajiv Kumar, Peter Dreger, Thomas Luft
Publikováno v:
Haematologica, Vol 104, Iss 4 (2019)
Increasing evidence suggests that endothelial cell distress is associated with mortality after allogeneic stem cell transplantation and acute graft-versus-host disease. Asymmetric dimethylarginine is an endogenous nitric oxide synthase inhibitor that
Externí odkaz:
https://doaj.org/article/cb5e0148c61a45b3aae89c94c7623030
Autor:
Lambros Kordelas, Carsten Müller-Tidow, Peter Dreger, Dietrich W. Beelen, Rajesh Kumar, Thomas Luft, Aleksandar Radujkovic, Hao Dai, Sivaramakrishna P. Rachakonda
Publikováno v:
Haematologica
Increasing evidence suggests that endothelial cell distress is associated with mortality after allogeneic stem cell transplantation and acute graft-versus-host disease. Asymmetric dimethylarginine is an endogenous nitric oxide synthase inhibitor that
Autor:
Peter Dreger, Carsten Müller-Tidow, Thomas Luft, Sivaramakrishna P. Rachakonda, Olga Blau, Aleksandar Radujkovic, Olaf Penack, Hao Dai, Igor Wolfgang Blau, Rajiv Kumar
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-12 (2021)
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-12 (2021)
Chronic graft-versus-host disease (cGVHD) is a major cause of mortality and morbidity after allogeneic stem cell transplantation (alloSCT). The individual risk of severe cGVHD remains difficult to predict and may involve CXCR3 ligands. This study inv
Autor:
Peter Dreger, Thomas Luft, Carsten Müller-Tidow, Hao Dai, Igor Wolfgang Blau, Olaf Penack, Rajesh Kumar, Aleksandar Radujkovic, Sivaramakrishna P. Rachakonda, Olga Blau
Publikováno v:
Journal of Clinical Oncology. 36:789-800
Purpose Endothelial vulnerability is a potential risk factor for complications after allogeneic stem-cell transplantation (alloSCT). The CD40/CD40 ligand (CD40L) axis contributes to inflammatory diseases and is upregulated in endothelial cells upon a
Publikováno v:
Oncotarget
Autor:
Victor Traves, Rajesh Kumar, Diana Reyes-Garcia, Celia Requena, Sivaramakrishna P. Rachakonda, Esperanza Manrique-Silva, Eduardo Nagore
Publikováno v:
Melanoma Research. 29:347-348
Autor:
Thomas Luft, Aleksandar Radujkovic, Sivaramakrishna P. Rachakonda, Rajiv Kumar, Peter Dreger, Olaf Penack, Hao Dai, I. W. Blau, Olga Blau, Carsten Müller-Tidow
Publikováno v:
Blood. 132:357-357
Introduction Severe chronic graft-versus-host disease (cGVHD) is the leading cause of morbidity and mortality in long-term survivors after allogeneic stem cell transplantation (alloSCT). The CXCR3 signalling pathway may be implicated in cGVHD pathoph
Autor:
Eduardo Nagore, Zaida García-Casado, Nalini Srinivas, Rajiv Kumar, Sivaramakrishna P. Rachakonda, Celia Requena
Publikováno v:
Cancer Research. 78:1407-1407
Telomeres at chromosomal ends are comprised of multiple short repeat sequences. In humans TTAGGG repeats account for 10-15 kb of double-stranded telomeres that end in single stranded G-rich tails of about 150-200 nucleotides. Telomeres in somatic cel
Autor:
Sascha Dietrich, Anthony D. Ho, Igor Wolfgang Blau, Sivaramakrishna P. Rachakonda, Olaf Penack, Olga Blau, Lutz Uharek, Aleksandar Radujkovic, Berend Isermann, Rajiv Kumar, Peter Dreger, Thomas Luft
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(30)
Purpose Steroid-refractory graft-versus-host disease (GVHD) is a major and often fatal complication after allogeneic stem-cell transplantation (alloSCT). Although the pathophysiology of steroid refractoriness is not fully understood, evidence is accu